C9149 – Injection, teplizumab-mzwv, 5 mcg
HCPCS Level II code · C codes: Outpatient PPS (Hospital Outpatient)
HCPCS codeC9149
- Long description
- Injection, teplizumab-mzwv, 5 mcg
- Short description
- Inj, teplizumab-mzwv, 5 mcg
- Pricing indicator
53Statute- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1EOther drugs- Added
- April 1, 2023
- Last change
- July 1, 2023 – No change
- Termination date
- June 30, 2023
Frequently asked questions
What is HCPCS code C9149?
C9149 is a HCPCS Level II code for injection, teplizumab-mzwv, 5 mcg. It was discontinued on June 30, 2023.
Does Medicare cover C9149?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby C codes
- C9141 – Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl (jivi), 1 i.u.
- C9142 – Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg
- C9143 – Cocaine hydrochloride nasal solution (numbrino), 1 mg
- C9144 – Injection, bupivacaine (posimir), 1 mg
- C9145 – Injection, aprepitant, (aponvie), 1 mg
- C9146 – Injection, mirvetuximab soravtansine-gynx, 1 mg
- C9147 – Injection, tremelimumab-actl, 1 mg
- C9148 – Injection, teclistamab-cqyv, 0.5 mg
- C9150 – Xenon xe-129 hyperpolarized gas, diagnostic, per study dose
- C9151 – Injection, pegcetacoplan, 1 mg
- C9152 – Injection, aripiprazole, (abilify asimtufii), 1 mg
- C9153 – Injection, amisulpride, 1 mg
- C9154 – Injection, buprenorphine extended-release (brixadi), 1 mg
- C9155 – Injection, epcoritamab-bysp, 0.16 mg
- C9156 – Flotufolastat f 18, diagnostic, 1 millicurie
- C9157 – Injection, tofersen, 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.